Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
- The Asia-Pacific biotechnology market recorded revenues of $364.5 billion in 2023, representing a compound annual growth rate (CAGR) of 10.5% between 2018 and 2023.
- The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $220.2 billion, equivalent to 60.4% of the market's overall value.
- The Asia-Pacific biotechnology market is experiencing growth due to innovation and potential therapeutic developments. Government initiatives are driving growth in the industry, such as Japan's $3 billion investment in the Drug Development Venture Ecosystem Enhancement Project and China's emphasis on research and development.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the Asia-Pacific biotechnology market by value in 2023?
- What will be the size of the Asia-Pacific biotechnology market in 2028?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's biotechnology market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Takeda Pharmaceutical Company Limite
- Shanghai Kehua Bio-engineering Co Ltd
- Astellas Pharma Inc.
- Daiichi Sankyo Co Ltd
